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Abstract
Background: Comparison of mortality among patients with positive and negative blood cultures may indicate the
contribution of bacteremia to mortality. This study (1) compared mortality among patients with community-
acquired bacteremia with mortality among patients with negative blood cultures and (2) determined the effects of
bacteremia type and comorbidity level on mortality among patients with positive blood cultures.
Methods: This cohort study included 29,273 adults with blood cultures performed within the first 2 days following
hospital admission to an internal medical ward in northern Denmark during 1995-2006. We computed product
limit estimates and used Cox regression to compute adjusted mortality rate ratios (MRRs) within 0-2, 3-7, 8-30, and
31-180 days following admission for bacteremia patients compared to culture-negative patients.
Results: Mortality in 2,648 bacteremic patients and 26,625 culture-negative patients was 4.8% vs. 2.0% 0-2 days
after admission, 3.7% vs. 2.7% 3-7 days after admission, 5.6% vs. 5.1% 8-30 days after admission, and 9.7% vs. 8.7%
31-180 days after admission, corresponding to adjusted MRRs of 1.9 (95% confidence interval (CI): 1.6-2.2), 1.1 (95%
CI: 0.9-1.5), 0.9 (95% CI: 0.8-1.1), and 1.0 (95% CI: 0.8-1.1), respectively. Mortality was higher among patients with
Gram-positive (adjusted 0-2-day MRR 1.9, 95% CI: 1.6-2.2) and polymicrobial bacteremia (adjusted 0-2-day MRR 3.5,
95% CI: 2.2-5.5) than among patients with Gram-negative bacteremia (adjusted 0-2-day MRR 1.5, 95% CI 1.2-2.0).
After the first 2 days, patients with Gram-negative bacteremia had the same risk of dying as culture-negative
patients (adjusted MRR 0.8, 95% CI: 0.5-1.1). Only patients with polymicrobial bacteremia had increased mortality
within 31-180 days following admission (adjusted MRR 1.3, 95% CI: 0.8-2.1) compared to culture-negative patients.
The association between blood culture status and mortality did not differ substantially by level of comorbidity.
Conclusions: Community-acquired bacteremia was associated with an increased risk of mortality in the first week
of medical ward admission. Higher mortality among patients with Gram-positive and polymicrobial bacteremia
compared with patients with Gram-negative bacteremia and negative cultures emphasizes the prognostic
importance of these infections.
Background
Community-acquired bacteremia is a serious condition
with a hospitalization rate of approximately 80 per
100,000 person-years [1] and a 30-day mortality greater
than 15% [2]. Mortality results from complex interac-
tions of factors including the infectious agent, host
immune response, underlying disorders, diagnostic
procedures, and medical interventions. These factors
and their effects can be difficult to untangle [3,4].
A comparison of mortality between patients with posi-
tive blood cultures and patients with negative blood cul-
tures may indicate the contribution of bacteremia to
mortality. Two hospital-based cohort studies have sug-
gested that 30-day mortality was two- to three-fold
higher among patients with bacteremia compared to
patients with negative blood cultures [4,5], while 1-year
mortality was similar between the two groups (mortality
rate ratio (MRR) 1.3, 95% confidence interval (CI): 0.76-
2.10) [5]. In contrast, an Israeli cohort study found that
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among patients with bacteremia and remained elevated
for up to 4 years, compared to patients with the same
underlying conditions but no infectious diseases [3].
Two other cohort studies from France and Canada iden-
tified bacteremia as a predictor of in-hospital mortality
in intensive care unit (ICU) patients with sepsis, severe
sepsis, or septic shock, with reported relative risks of 1.6
[6] and 1.7 [7], respectively. To date, no study has
focused on mortality in community-acquired bacteremia.
Other limitations of earlier studies include lack of long-
term follow-up [4,6,7], small sample size [5], and lack of
adjustment for coexisting chronic diseases [4,7].
To compare mortality among patients with commu-
nity-acquired bacteremia with that among patients with
negative blood cultures, controlling for potential con-
founders, we conducted a cohort study involving hospi-
talized internal medicine patients who had one or more
blood cultures performed within 2 days following admis-
sion. Our aims were (1) to examine the association
between blood culture status, defined as positive (i.e.
bacteremia) or negative blood cultures, and early mor-
tality (within 0-2 and 3-7 days following hospital admis-
sion), short-term mortality (within 8-30 days), and long-
term mortality (within 31-180 days); and (2) to deter-
mine the effects of bacteremia type and comorbidity
level on mortality among patients with blood cultures.
Materials and methods
Study setting and population
We conducted this population-based cohort study in
northern Denmark (population ~500,000) between 1995
and 2006. Universal access to free tax-supported health
care is provided in Denmark, and since 1968, each Dan-
ish resident has been assigned a civil registration num-
ber that permits unambiguous record linkage [8,9]. The
study included all patients over age 15 years who had
one or more blood cultures performed within 2 days of
hospital admission to an internal medicine ward. The 17
medical departments in the region represented general
internal medicine and the following medical specialties:
endocrinology, gastroenterology, geriatrics, hematology,
infectious diseases, nephrology, and pulmonary diseases.
Four allied specialty departments included cardiology,
medical oncology, neurology, and rheumatology. To be
eligible, patients had to have had no previous blood cul-
tures and no hospital contact during the preceding 30
days (Figure 1).
Blood culture data
Blood culture data were obtained from the laboratory
information system maintained by the Department of
Clinical Microbiology, Aalborg Hospital. Two blood cul-
ture systems were used during the study period: the
Colorbact system in 1995 (Statens Serum Institut,
Copenhagen, Denmark) [10] and the BacT/Alert system
(bioMérieux, Marcy l’Etoile, France) between 1996 and
2006. The nominal volume per blood culture was 20-22
mL for the Colorbact system and 28-32 mL for the
BacT/Alert system. Positive blood cultures were identi-
fied at fixed times and examined immediately by a tech-
nician [11]. On the basis of microscopy results, a first
telephone notification was made to the attending physi-
cians; antibiotic treatment was adjusted if deemed
necessary. As soon as the antibiotic susceptibility pattern
of the isolate was obtained, a second contact was made
either to confirm or adjust antibiotic treatment. Nega-
tive blood cultures were incubated for approximately 7
days and then a written report was sent to the attending
physicians.
Data on community-acquired bacteremia
We defined bacteremia as the presence of viable bacteria
or fungi in the bloodstream, evidenced in blood cultures
in which contamination had been ruled out [12]. We
regarded coagulase-negative staphylococci, Corynebac-
terium spp., Bacillus spp., and Propionibacterium acnes
as contaminants unless they were isolated from two or
more separate blood culture sets [12,13]. Community-
acquired bacteremia was defined as an infection present
or incubating at the time of admission [14]; thus, we
considered positive blood cultures obtained within the
first 2 days of admission as evidence of community-
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Figure 1 Flow diagram of the study population.
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Page 2 of 9acquired bacteremia. Patients with a hospital stay in the
30 days prior to admission or who had regular hospital
visits (e.g. for hemodialysis or chemotherapy) were cate-
gorized as having health care-associated bacteremia and
were not included in the study [15,16].
Patients with community-acquired bacteremia were
identified from the North Denmark Region Bacteremia
Research Database [12]. This database has recorded all
episodes of bacteremia since 1992 at the time of the
clinical episode. We categorized the bacteremia episodes
as Gram-positive, Gram-negative, polymicrobial bactere-
mia, and fungemia. Polymicrobial bacteremia was
defined as an episode with more than one clinically
important blood culture isolate detected within 48 hours
unless a new focus of infection had become apparent
[12,17].
Data on comorbidity and marital status
Comorbidity was classified according to the Charlson
Comorbidity Index (CCI) [18]. We computed CCI
scores based on all previous diagnoses recorded in the
Danish National Patient Registry, which has covered all
Danish hospitals since 1977. The diagnoses were coded
by physicians at discharge according to the International
Classification of Diseases, 8th revision (ICD-8) until the
end of 1993 and with the 10th revision (ICD-10) there-
after. We defined three levels of comorbidity: low (score
of 0), medium (scores of 1-2), and high (score of >2)
[19]. As a marker of social status [20,21], we obtained
information from the Civil Registration System on mari-
tal status (married, never married, divorced, or
widowed) on the date of the blood culture.
Statistical analysis
Data on mortality among study subjects were obtained
from the Civil Registration System [8,9]. Follow-up
started on the day of admission and extended for 180
days or until death or migration, whichever occurred
first. We constructed Kaplan-Meier curves and categor-
ized follow-up time into four intervals: early mortality
(within the first 0-2 days and at 3-7 days following
admission), short-term mortality (within 8-30 days fol-
lowing admission), and long-term mortality (within 31-
180 days following admission). To compare mortality
among patients with positive vs. negative blood cultures,
we computed product limit estimates and used Cox
regression analysis to compute MRRs for each time per-
iod with 95% confidence intervals (CI). The indications
for blood cultures may have changed over time, and all
models included adjustment for calendar period (1995-
1998, 1999-2002, and 2003-2006) as well as age (15-39,
40-59, 60-79, ≥ 80 years), gender, marital status, and
level of comorbidity.
Because some cultures might have been performed to
rule out bacteremia rather than because of a clinical
suspicion of bacteremia, we conducted an analysis
restricted to patients with a primary or secondary infec-
tious disease diagnosis in the hospital registry (please
see additional file 1: Hospital diagnoses and ICD-10
codes). We assumed that these patients had a high
degree of clinical suspicion of bacteremia. We also cate-
gorized bacteremia into different types and stratified the
analysis by comorbidity level. We graphically assessed
the assumption of proportional hazards in the Cox
model and found it appropriate for each follow-up inter-
val. Statistical analyses were performed using Stata Sta-
tistical Software v. 9.2 (Stata Corp., College Station, TX,
USA). The study was approved by the Danish Data Pro-
tection Agency (http://www.datatilsynet.dk/english/,
record no. 2006-41-7413). Data were obtained from
Danish registries, which are openly available to research-
ers, and their use does not require informed consent.
Records from the registries were linked by means of
each patient’s unique civil registration number, and after
record linkage, the data were de-identified.
Results
During the study period, we identified 179,917 patients
admitted to internal medicine departments, of whom
35,673 (19.8%) had at least one blood culture performed
within the first 2 days following admission. After exclu-
sion of patients hospitalized within the preceding 30
days (n = 6,084, 17.1%) and patients with non-commu-
nity-acquired bacteremia (n = 316, 1.1%), our study
population consisted of 29,273 internal medicine
patients. Of these, 26,625 (91.0%) had negative blood
cultures and 2,648 (9.1%) had community-acquired bac-
teremia (Figure 1). Table 1 presents the hospital registry
diagnoses of patients in the study population.
Patient characteristics
Patients with bacteremia were older (median age, 73;
interquartile range (IQR): 59-82 years) than patients
with negative blood cultures (median age, 68; IQR: 50-
79 years). Compared with culture-negative patients,
patients with bacteremia had slightly higher prevalences
of congestive heart failure, peripheral vascular disease,
peptic ulcer disease, and diabetes. Patients with negative
cultures had a higher prevalence of chronic pulmonary
disease (15.0% vs. 10.7% in patients with bacteremia)
(Table 2). Among patients with community-acquired
bacteremia, 53.5% had medium or high comorbidity
scores, compared with 50.1% of patients with negative
cultures.
Of patients with bacteremia, 84.1% had their first posi-
tive culture taken on the day of admission. In
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on the day of admission (Table 2). Among the 2,648
bacteremia patients, a total of 1,145 (43.2%) had Gram-
positive bacteremia while 1,340 (50.6%) had Gram-nega-
tive bacteremia, 160 (6.0%) had polymicrobial bactere-
mia, and 3 had fungemia (caused by Candida albicans,
Candida glabrata, and Saccharomyces cerevisiae, respec-
tively). Streptococcus pneumoniae accounted for 54.7%
of the Gram-positive pathogens, Staphylococcus aureus
accounted for 17.0%, and beta-hemolytic streptococci
for 13.3%. The Gram-negative bacteremias were predo-
minantly Enterobacteriacae (90.0%). Escherichia coli
accounted for 79.4% of all Gram-negative bacteremias.
Early and short-term mortality
Figure 2 shows mortality curves for patients during the
180 days following admission, stratified by blood culture
result and type of bacteremia. The overall mortality
within the first 2 days following admission was 2.0% in
patients with negative cultures and 4.8% in patients with
bacteremia (adjusted 0-2-day MRR 1.9, 95% CI 1.6-2.2)
(Table 3). Highest 0-2-day mortality was seen for patients
with polymicrobial bacteremia (9.2%, adjusted MRR 3.5,
95% CI 2.2-5.5). For patients with Gram-positive bactere-
mia and Gram-negative bacteremia, the 0-2-day mortality
was 4.7% (adjusted MRR 2.1, 95% CI 1.5-2.7) and 4.4%
(adjusted MRR 1.5, 95% CI 1.2-2.0), respectively.
The 3-7-day mortality rate was 3.7% in patients with
bacteremia and 2.7% in patients with negative cultures,
resulting in an adjusted MRR of 1.1 (95% CI: 0.9-1.5).
Patients with polymicrobial bacteremia had the highest
mortality rates (3-7-day mortality = 7.4%), followed by
patients with Gram-positive bacteremia (3-7-day mortal-
ity = 4.5%). Using culture-negative patients as the refer-
ence, the adjusted 3-7-day MRR was 1.4 (95% CI: 0.6-
3.1) for patients with polymicrobial bacteremia, 1.7 (95%
CI: 1.2-2.3) for patients with Gram-positive bacteremia,
and 0.8 (95% CI: 0.5-1.1) for patients with Gram-nega-
tive bacteremia (Table 4).
Death during days 8-30 following admission occurred in
5.6% of patients with bacteremia vs. 5.1% of patients with
negative cultures, equivalent to an adjusted MRR of 0.9
(95% CI: 0.8-1.1). The association between blood culture
status and mortality changed little with stratification by
type of bacteremia (Table 4). However, the estimates for
patients with polymicrobial bacteremia were imprecise.
Long-term mortality
For all patients alive on day 30 after admission, follow-
up lasted for 180 days. During days 31-180, 9.7% of
Table 1 Hospital diagnoses of 29,273 inpatients who were not hospitalized in the preceding 30 days and who had
blood cultures taken within the first 2 days of hospital admission‡.
Blood culture
Hospital registry diagnosis Negative No. (%) Positive No. (%)
Total 26,625 2,648
Acute or subacute infectious diseases
Primary discharge diagnosis 11,481 (43.1) 2,010 (75.9)
Primary or secondary discharge diagnosis 13,928 (52.3) 2,256 (85.2)
Pneumonia 7,107 (26.7) 678 (25.6)
Urinary tract infection 2,567 (9.6) 534 (20.2)
Intestinal infectious disease 1,034 (3.9) 77 (2.9)
Fever of unknown origin 768 (2.9) 20 (0.8)
Neoplasm 1,124 (4.2) 42 (1.6)
Anemia 283 (1.1) 9 (0.3)
Diabetes 406 (1.5) 12 (0.5)
Neurological or psychiatric disease 605 (2.3) 11 (0.4)
Cardiovascular disease 2,836 (10.7) 66 (2.5)
Respiratory disease 1,772 (6.7) 28 (1.1)
Gastrointestinal disease 1,062 (4.0) 87 (3.3)
Skin, connective tissue, or musculoskeletal disease 740 (2.8) 21 (0.8)
Renal and urinary tract disease 271 (1.0) 23 (0.8)
Symptoms without a specific diagnosis* 2,158 (8.3) 54 (2.1)
Injury and poisoning from medicines 317 (1.2) 6 (0.2)
Other
† 309 (1.2) 8 (0.3)
‡ For information about codes please see additional file 1: Hospital diagnoses and ICD-10 codes)
*Includes patients under evaluation for suspected diseases and conditions (~50%), patients with dehydration (~12%), patients with disorientation, dizziness,
headache, syncope or collapse (~12%), and patients with pain, nausea, or vomiting.
† Includes endocrine and metabolic disorders (other than diabetes), as well as diseases of the eye and ear.
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Page 4 of 9Table 2 Descriptive characteristics of 29,273 inpatients with one or more blood cultures taken within the first 2 days
following hospital admission.
Blood culture
Negative No. (%) Positive No. (%)
Total 26,625 (91.0) 2,648 (9.1)
Time of blood culture
Day of admission 20,158 (75.7) 2,228 (84.1)
First day following admission 4,921 (18.5) 368 (13.9)
Second day following admission 1,546 (5.8) 52 (2.0)
Calendar period
1995-1998 8,703 (32.7) 925 (35.0)
1999-2002 8,402 (31.6) 838 (31.7)
2003-2006 9,520 (35.8) 885 (33.4)
Marital status
Married 12,349 (46.4) 1,204 (45.5)
Never married 5,097 (19.1) 345 (13.0)
Divorced or widowed 8,902 (33.4) 1061 (40.1)
Unknown 277 (1.0) 38 (1.4)
Gender
Male 13,543 (50.9) 1,216 (45.9)
Female 13,082 (49.1) 1,432 (54.1)
Age group (years)
15-39 4,405 (16.5) 206 (7.8)
40-59 5,353 (20.1) 481 (18.2)
60-79 10,835 (40.7) 1,168 (44.1)
80 and older 6,032 (22.7) 793 (30.0)
Comorbidity
Previous myocardial infarction 1,720 (6.5) 182 (6.9)
Congestive heart failure 1,934 (7.3) 246 (9.3)
Peripheral vascular disease 1,451 (5.5) 181 (6.8)
Cerebrovascular disease 2,710 (10.2) 283 (10.7)
Dementia 434 (1.6) 41 (1.6)
Hemiplegia 121 (0.5) 6 (0.2)
Chronic pulmonary disease 3,992 (15.0) 284 (10.7)
Connective tissue disease 1,098 (4.1) 136 (5.1)
Peptic ulcer disease 1,794 (6.7) 211 (8.0)
Mild liver disease 355 (1.3) 62 (2.3)
Moderate to severe liver disease 84 (0.3) 20 (0.8)
Diabetes without end-stage organ damage 1,856 (7.0) 255 (9.6)
Diabetes with end-stage organ damage 888 (3.3) 103 (3.9)
Moderate to severe renal disease 647 (2.4) 73 (2.8)
Solid cancer 2,752 (10.6) 293 (11.6)
Metastatic solid cancer 376 (1.4) 50 (1.9)
Leukemia 172 (0.7) 16 (0.6)
Lymphoma 316 (1.2) 26 (1.0)
AIDS 28 (0.1) 3 (0.1)
Charlson Comorbidity Index Score
Low score (0) 13,297 (49.9) 1,231 (46.5)
Medium score (1-2) 9,654 (36.3) 993 (37.5)
High score (>2) 3,674 (13.8) 424 (16.0)
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patients with negative cultures (Table 4). The corre-
sponding adjusted MRR was 1.0 (95% CI: 0.8-1.1). Only
polymicrobial bacteremia was associated with increased
long-term mortality compared to negative cultures
(adjusted MRR 1.3, 95% CI: 0.8-2.1).
As Table 5 shows, mortalityi n c r e a s e dw i t hl e v e lo f
comorbidity. Within each level of comorbidity, commu-
nity-acquired bacteremia was associated with increased
early mortality. In an analysis restricted to patients with
a primary or secondary infectious disease diagnosis, we
found that mortality in bacteremia patients compared
with culture-negative patients was 4.4% vs. 1.7% after 0-
2 days, 3.4% vs. 2.2% after 3-7 days, 5.1% vs. 4.2% after
8-30 days, and 8.8% vs. 6.7% after 31-180 days, equiva-
lent to adjusted MRRs of 2.0 within 0-2 days, 1.3 (95%
CI: 1.0-2.7) within 3-7 days, 1.0 (95% CI: 0.8-1.3) within
8-30 days, and 1.1 (95% CI: 0.9-1.3) within 31-180 days
following hospital admission, respectively.
Discussion
In this study of 29,273 patients hospitalized in internal
medicine wards, we found a two-fold higher mortality
during the first 2 days following admission among
patients with community-acquired bacteremia compared
with patients with negative blood cultures. Thereafter,
mortality among patients with bacteremia was only
slightly higher than among patients with negative cul-
tures. Stratifying by type of bacteremia showed that
mortality was highest during the first week after admis-
sion among patients with Gram-positive and polymicro-
bial bacteremia, but patients with polymicrobial
bacteremia had an increased mortality for at least 180
days. After the first 2 days following admission, mortal-
ity in patients with Gram-negative bacteremia was simi-
lar to patients with negative blood cultures. The level of
comorbidity did not greatly influence the association
between blood culture status and mortality.
Although our use of data from population-based regis-
tries with complete follow-up and the universal health
care coverage in Denmark minimized selection bias, we
have to consider potential weaknesses when interpreting
our results. We had no data on the indications for per-
forming blood cultures. Therefore, to define a popula-
tion of patients with suspected community-acquired
bacteremia, we restricted the study to patients with
blood cultures performed within 2 days of admission to
an internal medicine ward and with no hospital contact
during the preceding 30 days. Because we defined our
condition of community-acquired bacteremia as any
positive blood culture obtained within the first 2 days
following hospital admission, the patient’s exposure sta-
tus could vary over the first 2 days of admission. Thus,
patients with negative blood cultures who died shortly
after admission may have had bacteremia that was
undiagnosed. Compared with patients with bacteremia,
culture-negative patients were less likely to have their
blood cultures taken on the day of admission, and as a
result, our relative estimates of mortality in the first 2
days following admission may have been biased because
of misclassification of exposure status. Some patients
with negative cultures may have had undetected bactere-
mia, particularly if they had received antimicrobial ther-
apy [22]; this lack of detection could have led to
underestimation of bacteremia-related mortality and
consequently to more conservative estimates of relative
mortality. Because we used administrative data lacking
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Figure 2 Mortality curves for the 29,273 patients by blood
culture result and type of bacteremia.
Table 3 Crude and adjusted risk of death within 0-2 days following hospital admission among inpatients who had one
or more blood cultures taken within 2 days of hospital admission.
Blood culture status n 0-2 days following admission
Mortality, % (95% CI) Crude MRR (95% CI) Adj. MRR* (95% CI)
Negative 26,625 2.0 (1.9-2.2) 1.0 (ref) 1.0 (ref)
Positive 2,648 4.8 (4.1-5.7) 2.2 (1.9-2.6) 1.9 (1.6-2.2)
Gram-positive 1,145 4.7 (3.6-6.1) 2.2 (1.7-2.8) 2.1 (1.6-2.7)
Gram-negative 1,340 4.4 (3.4-5.7) 1.9 (1.5-2.4) 1.5 (1.2-2.0)
Polymicrobial 160 9.2 (5.7-14.8) 4.6 (3.0-7.2) 3.5 (2.2-5.5)
*Adjusted for age, gender, level of comorbidity, marital status, and calendar period.
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patient’s clinical state at the time of blood culturing or
about potential empirical antibiotic treatment in patients
with negative blood cultures, which could have contrib-
uted to a favourable prognosis.
Measurement of disease severity in patients with com-
munity-acquired bacteremia poses a particular challenge
because it is difficult to assess disease severity at the
optimal time point immediately before the onset of bac-
teremia [23]. Therefore, some of the clinical data used
to calculate acute severity scores and the clinical presen-
tation actually may be influenced by the bacteremia.
Finally, we computed the CCI based on all previous
diagnoses recorded in the Danish National Patient Reg-
istry. The CCI is widely used but cannot assess the exis-
tence of comorbidity as accurately as clinical data [24].
Thus, inaccuracy of discharge data and diagnoses not
included in the index may have reduced our ability to
estimate comorbidity completely, and misclassification
may have led to residual confounding that could have
affected our mortality estimates. The validity of dis-
charge diagnoses registered in the Danish National
Patient Registry is variable but is generally high for the
diseases included in the CCI [25]. In any case, the
results of blood cultures obtained during a current
admission were unlikely to have affected the accuracy of
the diagnoses from previous admissions. Thus, any mis-
classification should bias the observed mortality esti-
mates toward unity.
By focusing on patients with community-acquired bac-
teremia and stratifying by type of bacteremia, our data
extend previous studies comparing the prognosis of
Table 4 Crude and adjusted risk of death within 3-7, 8-30, and 31-180 days following hospital admission among
inpatients with one or more blood cultures taken within 2 days of hospital admission.
Blood culture
status
3-7** days following admission 8-30 days following admission
† 31-180 days following admission
‡
Mortality, %
(95% CI)
Crude MRR
(95% CI)
Adj. MRR*
(95% CI)
Mortality, %
(95% CI)
Crude MRR
(95% CI)
Adj. MRR*
(95% CI)
Mortality, %
(95% CI)
Crude MRR
(95% CI)
Adj. MRR*
(95% CI)
Negative 2.7 (2.5-2.9) 1.0 (ref) 1.0 (ref) 5.1 (4.9-5.4) 1.0 (ref) 1.0 (ref) 8.7 (8.3-9.0) 1.0 (ref) 1.0 (ref)
Positive 3.7 (3.1-4.6) 1.3 (1.1-1.7) 1.1 (0.9-1.5) 5.6 (4.8-6.6) 1.1 (0.9-1.3) 0.9 (0.8-1.1) 9.7 (8.6-11.0) 1.1 (1.0-1.3) 1.0 (0.8-1.1)
Gram-positive 4.5 (3.4-5.9) 1.7 (1.3-2.4) 1.7 (1.2-2.3) 6.0 (4.7-7.6) 1.1 (0.9-1.5) 1.1 (0.8-1.4) 9.6 (7.9-11.6) 1.1 (0.9-1.4) 1.0 (0.8-1.3)
Gram-negative 2.7 (1.9-3.7) 1.0 (0.7-1.4) 0.8 (0.5-1.1) 5.2 (4.1-6.6) 1.0 (0.8-1.3) 0.8 (0.6-1.0) 9.3 (7.8-11.1) 1.1 (0.9-1.3) 0.9 (0.7-1.0)
Polymicrobial 7.4 (4.2-13.0) 1.9 (0.8-4.2) 1.4 (0.6-3.1) 6.6 (3.5-12.2) 1.5 (0.8-2.8) 1.1 (0.6-2.1) 14.8 (9.7-22.3) 1.7 (1.1-2.8) 1.3 (0.8-2.1)
*Adjusted for age, gender, level of comorbidity, marital status, and calendar period.
** For patients alive on day 3
†For patients alive on day 8.
‡For patients alive on day 31.
Table 5 Crude and adjusted risk of death within 0-2, 3-7, 8-30, and 31-180 days following hospital admission among
by level of comorbidity.
0-2 days following
admission
3-7 days following
admission**
8-30 days following
admission
†
31-180 days following
admission
‡
Comorbidity Blood
culture
status
Mortality,
% (95% CI)
Adjusted
MRR*
(95% CI)
Mortality,
% (95% CI)
Adjusted
MRR
(95% CI)
Mortality,
% (95% CI)
Adjusted
MRR
(95% CI)
Mortality,
% (95% CI)
Adjusted
MRR
(95% CI)
Low Negative 1.4 (1.2-1.6) 1.0 (ref) 1.9 (1.6-2.1) 1.0 (ref) 3.4 (3.1-3.7) 1.0 (ref) 5.0 (4.6-5.4) 1.0 (ref)
Positive 3.7 (2.8-5.0) 1.8 (1.4-2.5) 2.4 (1.6-3.4) 0.9 (0.6-1.4) 4.0 (3.0-5.3) 0.9 (0.7-1.2) 6.8 (5.4-8.4) 1.1 (0.8-1.4)
Medium Negative 2.3 (2.0-2.6) 1.0 (ref) 3.1 (2.8-3.5) 1.0 (ref) 6.1 (5.6-6.6) 1.0 (ref) 10.7
(10.0-11.3)
1.0 (ref)
Positive 5.3 (4.1-6.9) 1.9 (1.4-2.4) 4.3 (3.1-5.8) 1.4 (1.0-1.9) 5.9 (4.5-7.6) 0.9 (0.7-1.2) 10.9
(9.0-13.2)
0.9 (0.7-1.2)
High Negative 3.4 (2.9-4.1) 1.0 (ref) 4.5 (3.9-5.3) 1.0 (ref) 9.2 (8.3-10.2) 1.0 (ref) 18.1
(16.8-19.5)
1.0 (ref)
Positive 6.8 (4.8-9.7) 2.0 (1.5-2.9) 6.6 (4.5-9.5) 1.1 (0.7-1.9) 10.0
(7.4-13.6)
1.0 (0.7-1.5) 16.9
(13.3-21.4)
0.9 (0.7-1.2)
*Adjusted for age, gender, marital status, and calendar period.
** For patients alive on day 3.
†For patients alive on day 8.
‡For patients alive on day 31.
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Page 7 of 9patients with positive and negative blood cultures [4,5]. A
Canadian study found that patients with bacteremia had
higher in-hospital mortality in the 30 days after a positive
blood culture than patients with a negative blood culture
(27.3% vs. 7.3%) [4]. In line with that study, we observed
the highest mortality among patients with polymicrobial
bacteremia; however, the Canadian study, unlike the cur-
rent work, identified no difference in 30-day mortality
between bacteremia caused by Gram-positive cocci and
Gram-negative bacilli. Nonetheless, our result of a better
prognosis with Gram-negative bacteremia is corroborated
by the finding of a low mortality from E. coli bacteremia
with urinary tract foci in the Canadian study. In a single
hospital study from the US, Bates et al. [5] reported a
higher short-term mortality (adjusted 30-day MRR 2.3,
95% CI: 1.2-4.4) but less-affected long-term mortality
(adjusted 1-year MRR 1.3, 95% CI: 0.76-2.1) among 142
bacteremia patients compared with 142 patients with
negative blood cultures (matched by age, gender, severity
of underlying disease, and the presence of major comor-
bidity). Our study results are in accord with this result and
further suggest that the increased mortality associated
with community-acquired bacteremia occurs predomi-
nantly within the first days after admission. Conversely, an
Israeli study reported an increased long-term mortality in
patients with bacteremia when compared to controls with-
out infectious diseases, matched by age, gender, underlying
diseases, hospital department, and admission date (43% vs.
19% 180-day mortality rate) [3]. The use of different com-
parison cohorts most likely explains this discrepancy.
Recently, Laupland et al. [7] reported that bacteremia
was associated with a 60% increase in in-hospital mortal-
ity (crude OR 1.6, 95% CI: 1.1-2.2) among Canadian ICU
patients with sepsis. When they controlled for variables
that reflected the acute systemic response to infection,
the adjusted OR was 1.1 (95% CI: 0.7-1.8), suggesting
that the effect of bacteremia is mediated to a large extent
by the severity of the acute systemic inflammatory
response. Similarly, a study based on data from 170
French ICUs showed that bacteremia in patients with
severe sepsis or septic shock was associated with mortal-
ity within 3 days of ICU admission (adjusted OR 1.7, 95%
C I :1 . 1 - 2 . 8 )b u tn o ta t2 8d a y sa f t e ra d m i s s i o n[ 6 ] .W e
used overall mortality as our outcome measure because
of the difficulty of distinguishing the contributions to
mortality of the septic process and of underlying disor-
ders. However, the inclusion of patients with negative
blood cultures as a reference in our study is important
when interpreting our findings because we surmise that
patients with negative cultures had presented with several
essential signs of sepsis, not only pyrexia. Our MRRs
therefore may reflect the effect of bacteremia per se on
mortality. Although underlying comorbidities may have
influenced the physician’s decision to obtain blood
cultures, the association between blood culture status
and mortality remained robust in analyses restricted to
patients with infectious disease registry diagnoses and in
different comorbidity strata.
Conclusions
Community-acquired bacteremia was associated with a
markedly increased mortality in the first 2 days follow-
ing admission to a hospital internal medicine ward com-
pared with patients with negative cultures. However, the
excess mortality declined notably after that time,
emphasizing the clinical importance of prevention, early
detection, and effective empirical antibiotic treatment
for suspected but not yet proven bacteremia. Tradition-
ally, Gram-negative bacteria have received the most
attention because of their role in endotoxin-induced
shock. Our finding of higher mortality among patients
with Gram-positive and polymicrobial bacteremia is
clinically important and suggests that identification of
these types of infections requires greater attention.
Additional material
Additional file 1: Hospital diagnoses and ICD-10 codes. Hospital
diagnoses and corresponding ICD-10 codes of 29,273 inpatients who
were not hospitalized in the preceding 30 days and who had blood
cultures taken within the first 2 days of hospital admission.
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